MedPath

A pilot study on the effects of comprehensive Ayurveda intervention in participants with prediabetes.

Phase 2
Conditions
Health Condition 1: Z682- Body mass index (BMI) 20-29, adult
Registration Number
CTRI/2023/11/060199
Lead Sponsor
Center for Integrative Medicine & Research, All India Institute of Medical Sciences, New Delhi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Fulfill prediabetes diagnostic criteria [FPG (110-125 mg/dl) and / or OGTT (140-200 mg/dl)]

2.Capable and willing of giving signed consent form

Exclusion Criteria

1.Patients with H/o prior use of medication to treat diabetes/ prediabetes in last 3 months.

2.Currently using oral hypoglycemic agents

3.Decompensated cardiac, kidney, hepatic failure, endocrine disorder.

4.Pregnant and lactating females.

•Who have participated in any other interventional study in the past 3 months.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
•Reversal of prediabetes to normoglycemic state at 12 weeks. <br/ ><br>(The reversal of prediabetes will be determined by FPG 110mg/dl and 140 mg/dl of 2 hour- OGTT test.) <br/ ><br>Timepoint: Baseline, 12 weeks
Secondary Outcome Measures
NameTimeMethod
•Mean change in 2-hour OGTT at 12 weeks. <br/ ><br>•Mean change in FPG and HbA1c at 12 weeks <br/ ><br>•Mean change in homeostasis model assessment of Insulin resistance (HOMA-IR), Insulinogenic index and Disposition index at 12 weeks <br/ ><br>•Mean change in BMI at 12 weeks <br/ ><br>•Mean change in Quality of life (SF-36) at 12 weeks <br/ ><br>Timepoint: Baseline, 12 weeks
© Copyright 2025. All Rights Reserved by MedPath